TIDMRDT
RNS Number : 0496A
Rosslyn Data Technologies PLC
31 January 2022
Rosslyn Data Technologies plc
(the "Company", "RDT" or the "Group")
Interim results for the six months ended 31 October 2021
Rosslyn (AIM:RDT), the provider of a leading cloud based
enterprise data analytics platform announces its interim results
for the six months ended 31 October 2021.
Highlights
-- Significant Investment into core Rapid product, which
includes: a transformation of the UI/UX interface, a foundation
architecture built to deliver advanced intelligent automation and
machine learning; and an enhancement to the product's data mining
capabilities.
-- Group revenues of GBP3.1 million (H1 2021: GBP3.6 million)
and gross profit margin of 81.7% (H1 2021 82.2%)
-- Administrative expenses increased to GBP3.91 million (H1
2021: GBP3.14 million) as a result of investment into product
Marketing
-- Operating EBITDA loss was GBP1.38 million (H1 2021: GBP146,000 loss)
-- Annual Recurring Revenue ("ARR") of GBP5.3 million (H1 FY2021: GBP6.2 million)
-- We have won three major new deals during this period,
including a large 7-figure contract with one of the largest
pharmaceutical companies in the world.
Paul Watts, CEO commented, " Much has been accomplished during
the first half of the year to set the Group on a growth trajectory.
There was much change in the business set against a complex
external operating environment as a result of Covid. However, I
believe the Group is now on the right path; we have an ambitious
new leadership team in place with a desire and focus to drive
growth. The development upgrades to our core RAPid product,
together with a brand refresh, will, I believe, fully transform our
business and enable us to adopt a new approach to drive
scalability, broaden the number of potential users. As we now enter
the next phase of our turnaround project, I believe the market
opportunity for Rosslyn has never been greater and am excited about
what the future holds."
+44(0) 7555 144983
Rosslyn Data Technologies Paul Watts, Chief Executive +44(0)20 3285
plc Officer 8008
+44 (0) 7940
James Appleby, Chairman 560624
Cenkos Securities,
Nominated Adviser, Stephen Keys/Camilla Hume/Giles +44(0)20 7397
Broker Balleny 8900
Chief Executive's Review
The first half year has been an exciting one at Rosslyn where we
have embarked on and completed the first phase of a major
restructure of our business strategy. On taking over as CEO in
April 2021, I instigated a deep dive audit of the core assets
within the business. This included not only looking at the
products, but also our execution capability across R&D,
marketing, sales, and customer support.
The audit project was completed by the middle of the year, with
a number of key observations;
-- The Company's core RAPid product still has a strong value
proposition within the spend analytics marketplace but was in need
of some major modernisation; primarily to transform the user
experience, but also to extend the core value of this data deeper
into where spend and supplier information management overlap. As
such we have invested heavily in developing the next generation of
the RAPid product to address these needs which is expected to be
launched before the end of March 2022;
-- The R&D function has established a product strategy group
within the company to better capture requirements and focus on next
generation intelligent automation technology,
As much as the feedback captured from customers was positive, it
was felt essential that we form a Customer Advisory Board, to marry
our strategic product roadmap with the customer's experiences and
objectives , which met for the first time in January 2022.
As a result of the operational overview conducted, we have
refreshed the Group's Operational Leadership Team, which now
consists of 80% new employees all coming from within the B2B SaaS
enterprise software space, with a proven track record for executing
successful turnaround projects. This team has now been in place for
4-months and I am extremely pleased with how the team is working
together.
Importantly we have now have the leadership in place and a
focussed strategy upon which to execute which includes, amongst
other things;
-- To return the business to focus on one core product, that has
the highest growth potential, our spend analytics platform, RAPid.
This is the Rosslyn spend analytics platform.
-- To re-brand Rosslyn, in early 2022, in tandem with the launch
of the new version of the software, to present ourselves as a
modern focused visionary thought-leader in our market place,
underpinned with the most industrial strength solution.
As previously stated the Integritie and Langdon Systems
acquisitions, whilst performing well since they became part of the
Group, have limited crossover in terms of customer base or
strategic rationale. As a result, we are continuing to evaluate how
to best capitalize on the Group's core business and deliver the
best value to shareholders, which may include the divestment of
these non-core elements of the Group.
With a clear strategy now in place for the second half of the
year, the focus has shifted to execution of this strategy in order
to drive growth and deliver shareholder value. Our objectives in
the second half of the year will be:
-- To establish core KPI's by which to drive and measure the
success of the business in line with industry best practice for B2B
SaaS enterprise software;
-- To empower the new leadership team with an entrepreneurial
operating model to drive their line of business in a fully
collaborative environment;
-- To put the customer experience at the centre of our business,
with a laser focus on ensuring they extract maximum value from our
solution;
-- To release the new version of Rosslyn with strong customer,
partner and analyst endorsement;
-- To launch the new re-branded Rosslyn into the marketplace,
with voice of customer, and product strategy being at the centre of
our core values; and
-- To modernise the go-to-market model to incorporate a strong
focus on partners. This comes out the back of significant wins with
both new and established partners in the first half.
Operational Update
At this time of restructuring, and a change in corporate
strategy towards being a single product company we have continued
to focus on executing at an operational level.
Our primary focus has been around securing a stronger alignment
between our product strategy and customer success execution. We
have employed new leadership for both parts of this business. We
have also formed our first Customer Advisory Board and produced our
first product roadmap with full customer validation. Combining this
customer input with the work completed during our strategic audits
in mid-year, as well as recent positive reviews from key analysts
like SpendMatters (Rosslyn was nominated as a Top-50 vendors in
procurement to watch in 2022), give us confidence for the
future.
We have won three major new deals during this period, including
a large 7-figure contract with one of the largest pharmaceutical
companies in the world. There have also been key wins with our
partners in the USA and the UK. We will look to expand our partner
strategy in 2022, as there is a strong trend across procurement
transformation towards architecting best of breed technology.
Our development team is now in Beta testing stage with customers
for the highly anticipated Rosslyn-10 platform. This new version
will provide the foundation for accelerated enhancements through
2022, as we move our core technology to one that can truly leverage
agile development best practice and be deployed in a true SaaS way.
This first release will be a complete transformation of the user
interface and is focused on democratising complex data technology
to non-IT procurement professionals.
Outlook
Rosslyn now finds itself with a new leadership team of
experienced professionals from the software industry, who are
charged with our next phase of execution. The combination of
bringing together the customer and product as the central nervous
system of our execution, and the relaunching of a new brand into
the market we expect to give us a springboard into 2022 and beyond.
We look to the future with increasing confidence.
Consolidated statement of comprehensive income
For the six months ended 31 October 2021
Six months Six months Year
ended ended ended
31 October 31 October 30 April
2021 2020 2021
Unaudited Unaudited Audited
Notes GBP'000 GBP'000 GBP'000
------------------------------------------- ----- ----------- ----------- ---------
Revenue 3 3,094 3,573 7,417
Cost of sales (565) (636) (1,316)
------------------------------------------- ----- ----------- ----------- ---------
Gross profit 2,529 2,937 6,101
Other operating income 4 - 54 89
Administrative expenses (3,905) (3,137) (7,248)
Depreciation and amortisation (566) (567) (1,106)
Share based payment (61) (120) (204)
Operating loss (2,003) (833) (2,368)
Finance income 3 17 34
Finance costs (50) (67) (124)
Loss before income tax (2,050) (883) (2,458)
Income tax credit 156 171 486
------------------------------------------- ----- ----------- ----------- ---------
Loss for the period (1,894) (712) (1,972)
------------------------------------------- ----- ----------- ----------- ---------
Other comprehensive loss - - (2)
Total comprehensive income (1,894) (712) (1,974)
------------------------------------------- ----- ----------- ----------- ---------
Loss per share
Basic and diluted loss per share: ordinary
shareholders (pence) 5 (0.56) (0.21) (0.60)
------------------------------------------- ----- ----------- ----------- ---------
Consolidated balance sheet
As at 31 October 2021
31 October 31 October 30 April
2021 2020 2021
Unaudited Unaudited Audited
GBP'000 GBP'000 GBP'000
----------------------------------- ---------- ---------- --------
ASSETS
Non-current assets
Intangible assets 512 1,491 994
Property, plant and equipment 52 17 55
Right-of-use assets 368 99 73
----------------------------------- ---------- ---------- --------
932 1,607 1,122
----------------------------------- ---------- ---------- --------
Current assets
Trade and other receivables 1,817 2,548 2,354
Corporation tax receivable 429 332 309
Cash and cash equivalents 4,834 7,227 6,681
----------------------------------- ---------- ---------- --------
7,080 10,107 9,344
----------------------------------- ---------- ---------- --------
Total assets 8,012 11,714 10,466
----------------------------------- ---------- ---------- --------
LIABILITIES
Current liabilities
Trade and other payables (4,281) (4,331) (4,489)
Financial liabilities - borrowings (726) (388) (890)
----------------------------------- ---------- ---------- --------
(5,007) (4,719) (5,379)
----------------------------------- ---------- ---------- --------
Non-current liabilities
Trade and other payables (173) (414) (386)
Deferred tax (36) (109) (73)
Financial liabilities - borrowings - (666) -
----------------------------------- ---------- ---------- --------
(209) (1,189) (459)
----------------------------------- ---------- ---------- --------
Total liabilities (5,216) (5,908) (5,838)
----------------------------------- ---------- ---------- --------
Net assets/(liabilities) 2,796 5,806 (4,628)
----------------------------------- ---------- ---------- --------
Equity
Called up share capital 1,699 1,699 1,699
Share premium 18,923 18,923 18,923
Share-based payment reserve 580 590 657
Accumulated loss (23,416) (20,419) (21,662)
Translation reserve (123) (120) (122)
Merger reserve 5,133 5,133 5,133
----------------------------------- ---------- ---------- --------
Total equity 2,796 5,806 4,628
----------------------------------- ---------- ---------- --------
Consolidated cash flow statement
For the six months ended 31 October 2021
Six months Six months Year
ended ended ended
31 October 31 October 30 April
2021 2020 2021
Unaudited Unaudited Audited
GBP'000 GBP'000 GBP'000
----------------------------------------------------- ----------- ----------- ---------
Cash flows from operating activities
Loss before income tax (2,050) (883) (2,458)
Adjustments for:
- depreciation, amortisation 566 569 1,106
- share-based payments 61 120 204
- finance income (3) (17) (34)
- finance costs 50 67 124
(1,376) (144) (1,058)
Increase/(decrease) in receivables 537 (509) (317)
Increase/(decrease) in payables (776) 431 601
----------------------------------------------------- ----------- ----------- ---------
Cash used from operations (1,615) (222) (774)
Finance income 3 17 34
Finance costs (50) (67) (124)
Corporation tax received - - 301
Net cash used in operating activities (1,662) (272) (563)
----------------------------------------------------- ----------- ----------- ---------
Cash flows from investing activities
Purchase of property, plant and equipment (21) (13) (66)
Net cash used in investing activities (21) (13) (66)
----------------------------------------------------- ----------- ----------- ---------
Cash flows from financing activities
Proceeds from share capital issued (net) - 7,352 7,352
Costs of share issue - (472) (472)
Repayment of bank and other borrowings (164) (162) (364)
Net cash from/(used in) financing activities (164) 6,718 6,516
----------------------------------------------------- ----------- ----------- ---------
Net increase/(decrease) in cash and cash equivalents (1,847) 6,433 5,887
Cash and cash equivalents at beginning of period 6,681 794 794
Cash and cash equivalents at end of period 4,834 7,227 6,681
----------------------------------------------------- ----------- ----------- ---------
Notes to the unaudited interim statements
For the six months ended 31 October 2021
1. Basis of preparation
This interim report has been prepared in accordance with the
accounting policies disclosed in the full statutory accounts for
the year ended 30 April 2021.
These policies are in accordance with UK-adopted international
accounting standards that are expected to be applicable for the
year ending 30 April 2022.
The Group has chosen not to adopt IAS 34 "Interim Financial
Statements" in preparing the interim consolidated financial
information.
The financial information in this statement relating to the six
months ended 31 October 2021 and the six months ended 31 October
2020 has not been audited.
The financial information for the year ended 30 April 2021 does
not constitute the full statutory accounts for that period. The
annual report and financial statements for the year ended 30 April
2021 has been filed with the Registrar of Companies.
The Independent Auditor's Report on the annual report and
financial statements for the year ended 30 April 2021 was
unqualified, did not draw attention to any matters by way of
emphasis and did not contain a statement under Section 498(2) or
498(3) of the Companies Act 2006.
The interim report for the period ended 31 October 2021 was
approved by the Board of Directors on 28 January 2022.
2. Segmental reporting
Management has determined the operating segments based on the
operating reports reviewed by the Executive Directors that are used
to assess both performance and strategic decisions. Management has
identified that the Executive Directors are the Chief Operating
Decision-Maker in accordance with the requirements of IFRS 8
Operating segments.
The determination is that the Group operates as a single
segment, as no internal reporting is produced either by geography
or division. The Group does view performance on the basis of the
type of revenue, and the end destination of the client as shown
below.
Six months Six months Year
ended ended ended
31 October 31 October 30 April
2021 2020 2021
Unaudited Unaudited Audited
Analysis of Revenue by Product GBP'000 GBP'000 GBP'000
------------------------------- ----------- ----------- ---------
Annual licence fees 2,675 2,947 5,962
Professional services 419 626 1,455
------------------------------- ----------- ----------- ---------
Total revenue 3,094 3,573 7,417
------------------------------- ----------- ----------- ---------
Six months Six months Year
ended ended ended
31 October 31 October 30 April
2021 2020 2021
Unaudited Unaudited Audited
Analysis of Revenue by Country GBP'000 GBP'000 GBP'000
------------------------------- ----------- ----------- ---------
United Kingdom 1,989 2,127 4,579
Europe 461 770 1,457
North America 644 676 1,381
------------------------------- ----------- ----------- ---------
Total revenue 3,094 3,573 7,417
------------------------------- ----------- ----------- ---------
Included in Europe is the Netherlands which had revenues of
GBP181,000 in the period ended 30 October 2021 (2020:
GBP475,000).
Included in North America is the USA which had revenues of
GBP559,000 in the period ended 30 October 2021 (2020:
GBP532,000).
Six months Six months Year
ended ended ended
31 October 31 October 30 April
2021 2020 2021
Unaudited Unaudited Audited
Analysis of Future Obligations GBP'000 GBP'000 GBP'000
----------------------------------------------- ----------- ----------- ---------
Performance obligations to be satisfied in the
next year 3,217 2,601 3,865
Performance obligations to be satisfied after
31 October 2022 1,753 3,305 1,951
Total future performance obligations 4,970 5,906 5,816
----------------------------------------------- ----------- ----------- ---------
Six months Six months Year
ended ended ended
31 October 31 October 30 April
2021 2020 2021
Unaudited Unaudited Audited
Analysis of Largest Customer GBP'000 GBP'000 GBP'000
---------------------------------- ----------- ----------- ---------
Annual Licence fees 258 215 360
Professional Services 0 0 95
Total revenue of largest customer 258 215 455
---------------------------------- ----------- ----------- ---------
There were no significant customers who make up greater than 10%
of total revenue in the period.
3. Operating EBITDA
Operating EBITDA is calculated from Operating loss as shown
below.
Six months Six months Year
ended ended ended
31 October 31 October 30 April
2021 2020 2021
Unaudited Unaudited Audited
GBP'000 GBP'000 GBP'000
------------------------------ ----------- ----------- ---------
Operating loss (2,003) (833) (2,368)
Depreciation and amortisation 566 567 1,106
Share-based payments 61 120 204
Operating EBITDA (1,376) (146) (1,058)
------------------------------ ----------- ----------- ---------
4. Other operating income
Other operating income is amounts received in the form of
furlough payments and similar non-repayable grants from government
bodies as a result of the coronavirus pandemic.
5. Earnings per share
Basic earnings per share is calculated by dividing the net loss
for the period attributable to ordinary shareholders by the
weighted average number of ordinary shares outstanding during the
period. Diluted earnings per share is calculated by dividing net
loss for the period attributable to ordinary shareholders by the
weighted average number of ordinary shares outstanding during the
period plus the weighted average number of ordinary shares that
would be issued on the conversion into ordinary shares of all
potentially dilutive instruments. In the periods ended 31 October
2021, 31 October 2020 and 30 April 2021 there were share options in
issue which could potentially have a dilutive impact, but as the
Group was loss making they were anti-dilutive for each period and
therefore the weighted average number of ordinary shares for the
purpose of the basic and dilutive loss per share were the same.
Six months Six months Year
ended ended ended
31 October 31 October 30 April
2021 2020 2021
Unaudited Unaudited Audited
-------------------------------------------------------- ------------ ----------- ------------
Loss for the period attributable to the owners GBP1,894,000 GBP712,000 GBP1,972,000
of the parent
Weighted average number of ordinary shares 339,842,521 339,066,662 328,655,751
Pence Pence Pence
Basic and diluted loss per share: ordinary shareholders (0.56) (0.21) (0.60)
-------------------------------------------------------- ------------ ----------- ------------
6. Dividends
No interim dividend (2020: nil) will be paid to
shareholders.
7. Principal risks and uncertainties
The principal risks and uncertainties for this six-month period
remain broadly consistent with those set out in the Financial
Review section of the financial statements of the Group for the
year ended 30 April 2021.
8. Interim report
Copies of the interim report are available to the public on the
Group's website at www.rosslyndatatech.com, and from the registered
offices of Rosslyn Data Technologies plc at 1000 Lakeside North
Harbour, Western Road, Portsmouth, Hampshire, England, PO6 3EN or
by email to investors@rosslyndatatech.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
IR FLFSDLRITFIF
(END) Dow Jones Newswires
January 31, 2022 01:59 ET (06:59 GMT)
Rosslyn Data Technologies (LSE:RDT)
Historical Stock Chart
From Apr 2024 to May 2024
Rosslyn Data Technologies (LSE:RDT)
Historical Stock Chart
From May 2023 to May 2024